title: Vascular delay and administration of basic fibroblast growth factor augment latissimus dorsi muscle flap perfusion and function.
abstract: Ischemia of the distal latissimus dorsi muscle flap occurs when the entire muscle is acutely elevated. Although this level of ischemia may not be critical if the muscle is to be used as a conventional muscle flap, the ischemia causes decreased distal muscle function if it is used for dynamic muscle flap transfer. This experiment was designed to determine whether or not the administration of exogenous basic fibroblast growth factor (bFGF), combined with a sublethal ischemic insult (i.e., vascular delay), would further augment muscle perfusion and function. Both latissimus dorsi muscles of nine canines were subjected to a bipedicle vascular delay procedure immediately followed by thoracodorsal intraarterial injection of 100 microg of bFGF on one side and by intraarterial injection of vehicle on the other. Ten days later, both latissimus dorsi muscles were raised as thoracodorsally based island flaps, with perfusion determined by laser-Doppler fluximetry. The muscles were wrapped around silicone chambers, simulating cardiomyoplasty, and stimulating electrodes were placed around each thoracodorsal nerve. The muscles were then subjected to an experimental protocol to determine muscle contractile function. At the end of the experiment, latissimus dorsi muscle biopsies were obtained for measurement of bFGF expression. The results demonstrated that the administration of 100 microg of bFGF immediately after the vascular delay procedure increases expression of native bFGF. In the distal and middle muscle segments, it also significantly increased muscle perfusion by approximately 20 percent and fatigue resistance by approximately 300 percent. The administration of growth factors may serve as an important adjuvant to surgical procedures using dynamic muscle flap transfers.
authors.affiliation: Department of Surgery, School of Medicine, University of Louisville, KY, USA.
authors.forename: S M
authors.initials: SM
authors.lastname: Carroll
authors.forename: C M
authors.initials: CM
authors.lastname: Carroll
authors.forename: R W
authors.initials: RW
authors.lastname: Stremel
authors.forename: S J
authors.initials: SJ
authors.lastname: Heilman
authors.forename: J M
authors.initials: JM
authors.lastname: Steffen
authors.forename: G R
authors.initials: GR
authors.lastname: Tobin
authors.forename: J H
authors.initials: JH
authors.lastname: Barker
mesh_terms: D000818:Animals; D015153:Blotting, Western; D004285:Dogs; D004558:Electric Stimulation; D016222:Fibroblast Growth Factor 2 / Q000032:analysis / Q000494:pharmacology* / Q000502:physiology; D019194:Ischemic Preconditioning; D017078:Laser-Doppler Flowmetry; D009119:Muscle Contraction; D018482:Muscle, Skeletal / Q000098:blood supply* / Q000378:metabolism; D012039:Regional Blood Flow; D013524:Surgical Flaps / Q000098:blood supply* / Q000502:physiology
chemical_list: D016222:Fibroblast Growth Factor 2